SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-003097
Filing Date
2014-05-12
Accepted
2014-05-12 08:01:11
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0314_soligenix.htm 10-Q 658514
2 CERTIFICATION f10q0314ex31i_soligenix.htm EX-31.1 15396
3 CERTIFICATION f10q0314ex31ii_soligenix.htm EX-31.2 15575
4 CERTIFICATION f10q0314ex32i_soligenix.htm EX-32.1 6017
5 CERTIFICATION f10q0314ex32ii_soligenix.htm EX-32.2 6050
  Complete submission text file 0001213900-14-003097.txt   4464868

Data Files

Seq Description Document Type Size
6 XBRL sngx-20140331.xml EX-101.INS 672891
7 XBRL sngx-20140331.xsd EX-101.SCH 33459
8 XBRL sngx-20140331_cal.xml EX-101.CAL 30825
9 XBRL sngx-20140331_def.xml EX-101.DEF 93778
10 XBRL sngx-20140331_lab.xml EX-101.LAB 305598
11 XBRL sngx-20140331_pre.xml EX-101.PRE 193867
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 14831325
SIC: 2834 Pharmaceutical Preparations